Streetbeat News

Analyst Ratings

VZ

Tigress Financial has maintained a Buy rating on Verizon Communications and raised its price target from $52 to $55, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 4:04 pm

PTN

HC Wainwright & Co. has reiterated its Buy rating on Palatin Technologies (AMEX:PTN) and maintained a price target of $17, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 4:02 pm

AAPL

Barclays analyst Tim Long maintains an Underweight rating on Apple with a price target of $186.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 4:01 pm

HUM

Over the past three months, 12 analysts have evaluated Humana (NYSE:HUM), with a range of opinions from bullish to bearish. The average 12-month price target has increased by 3.72% to $388.0. Analysts have adjusted their ratings and price targets, reflecting their response to recent developments related to Humana. The company has shown impressive revenue growth but faces challenges with net margin and debt management.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 4:01 pm

V

Analysts have varied ratings for Visa (NYSE:V) over the last quarter, with a mix of bullish and bearish sentiments. The average 12-month price target has slightly increased to $310.59. Visa's financials show strong net margins and ROE, but its revenue growth lags behind industry peers.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 4:01 pm

BELFB

Over the past three months, analysts have shown varied opinions on Bel Fuse (NASDAQ:BELFB), with a recent increase in the average 12-month price target to $83.5. Analysts have raised their ratings and price targets, reflecting a positive outlook despite recent revenue challenges.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 4:00 pm

GLPI

Gaming and Leisure Properties Inc. (GLPI) has received 12 analyst ratings over the past three months, with a mix of bullish and indifferent sentiments. Analysts have raised their 12-month price targets, reflecting a positive outlook. The company's financial performance shows strong net margins and return on equity, although revenue growth lags behind industry peers.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 4:00 pm

THC

Fifteen analysts have recently evaluated Tenet Healthcare (NYSE:THC), showing a range of sentiments from bullish to somewhat bullish. The average 12-month price target has increased by 11.98% to $162.6, with a high of $197.00 and a low of $112.00. Analysts have mostly raised their ratings and price targets, indicating positive sentiment. Tenet Healthcare has shown positive revenue growth and strong financial metrics, but its high debt-to-equity ratio poses potential challenges.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 4:00 pm

UHS

Analysts have varied opinions on Universal Health Services (NYSE:UHS) with recent ratings showing a mix of bullish, neutral, and bearish sentiments. The average 12-month price target has increased to $217.69, indicating positive expectations. UHS has shown strong financial performance with significant revenue growth and profitability metrics surpassing industry averages.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 4:00 pm

DHR

Danaher Corp (NYSE:DHR) is expected to have a gradual recovery in 2025, with high-single-digit growth in the long term, according to Stifel analyst Jacob Johnson. The company, now a pure-play life sciences tools company, has faced recent headwinds but is poised for a good year in bioprocessing.

Portfolio Pulse from Priya Nigam

October 01, 2024 | 3:58 pm